Document is current
Any future updates will be listed below
-
Authors
Toupin-April, Karine https://orcid.org/0000-0003-0141-7193
Gaboury, Isabelle
Proulx, Laurie
Huber, Adam M.
Duffy, Ciarán M.
Morgan, Esi M.
Li, Linda C.
Stringer, Elizabeth
Connelly, Mark
Weiss, Jennifer E.
Gibbon, Michele
Sachs, Hannah
Sivakumar, Aditi
Sirois, Alexandra
Sirotich, Emily
Trehan, Natasha
Abrahams, Naomi
Cohen, Janice S.
Cavallo, Sabrina
Hindi, Tania El
Ragusa, Marco
Légaré, France
Brinkman, William B.
Fortin, Paul R.
Décary, Simon
Lee, Rebecca
Gmuca, Sabrina
Paterson, Gail
Tugwell, Peter
Stinson, Jennifer N.
-
Funding
Funding for this research was provided by:
Arthritis Society Canada
- License Information
-
More Information
Article History
Received: 5 April 2023
Accepted: 14 June 2023
First Online: 26 July 2023
Declarations
:
: The Children’s Hospital of Eastern Ontario (CHEO) Research Ethics Board approved this study (REB#16/100X) and participants signed consent/assent forms.
: We confirm that all authors have approved the manuscript for submission. Also, I, Karine Toupin April, confirm that the manuscript has not been published, and have not been submitted for publication elsewhere.
: LCL holds the Harold Robinson/Arthritis Society Chair in Arthritic Diseases.PT has reported receiving an honorarium as a member of an independent advisory panel for the Reformulary Group and as a member of a Safety and Monitoring Committee for a biologic for Parexel International and has reported co-chairing the OMERACT executive committee.WBB has common stock in the following publicly traded companies: Pfizer, Merck, Abbott Laboratories, Viatris, Johnson & Johnson.EMM is the principal investigator of the Pediatric Rheumatology Care and Outcomes Improvement Network.
